Weekly Investment Analysts’ Ratings Changes for HCA Healthcare (HCA)

Several analysts have recently updated their ratings and price targets for HCA Healthcare (NYSE: HCA):

• 5/19/2026 – HCA Healthcare had its price target lowered by JPMorgan Chase & Co. from $535.00 to $490.00. They now have a “neutral” rating on the stock.
• 5/18/2026 – HCA Healthcare was downgraded by Weiss Ratings from “buy (b)” to “buy (b-)”.
• 5/4/2026 – HCA Healthcare had its price target lowered by Argus from $560.00 to $500.00. They now have a “buy” rating on the stock.
• 5/2/2026 – HCA Healthcare was downgraded by Wall Street Zen from “buy” to “hold”.
• 4/28/2026 – HCA Healthcare had its price target lowered by Sanford C. Bernstein from $541.00 to $503.00. They now have a “market perform” rating on the stock.
• 4/28/2026 – HCA Healthcare had its price target lowered by Deutsche Bank Aktiengesellschaft from $558.00 to $540.00. They now have a “buy” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by Wells Fargo & Company from $481.00 to $436.00. They now have an “equal weight” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by KeyCorp from $550.00 to $510.00. They now have an “overweight” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by Barclays PLC from $551.00 to $496.00. They now have an “overweight” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by Stephens from $560.00 to $530.00. They now have an “overweight” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by Oppenheimer Holdings, Inc. from $540.00 to $520.00. They now have an “outperform” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by TD Cowen from $561.00 to $500.00. They now have a “buy” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by Leerink Partners from $573.00 to $500.00. They now have an “outperform” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by Royal Bank Of Canada from $593.00 to $534.00. They now have an “outperform” rating on the stock.
• 4/27/2026 – HCA Healthcare had its price target lowered by Truist Financial Corporation from $546.00 to $535.00. They now have a “buy” rating on the stock.
• 4/24/2026 – HCA Healthcare had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. They now have a $525.00 price target on the stock.
• 4/15/2026 – HCA Healthcare had its price target lowered by Robert W. Baird from $450.00 to $442.00. They now have a “neutral” rating on the stock.
• 3/27/2026 – HCA Healthcare had its “buy (b)” rating reaffirmed by Weiss Ratings.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be paid a dividend of $0.78 per share. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio is 10.73%.

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.